Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke

被引:133
作者
Suarez, JI
Sunshine, JL
Tarr, R
Zaidat, O
Selman, WR
Kernich, C
Landis, DMD
机构
[1] Univ Hosp Cleveland, Dept Neurol, Cleveland, OH 44106 USA
[2] Univ Hosp Cleveland, Dept Neuroradiol, Cleveland, OH 44106 USA
[3] Univ Hosp Cleveland, Dept Neurosurg, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Cleveland, OH 44106 USA
关键词
hemorrhage; stroke; ischemic; thrombolysis;
D O I
10.1161/01.STR.30.10.2094
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-We sought to evaluate predictors of clinical outcome, angiographic success, and adverse effects after intra-arterial administration of urokinase for acute ischemic stroke. Methods-We designed a Brain Attack program at University Hospitals of Cleveland for diagnosis and treatment of patients presenting within 6 hours of onset of neurological deficit. Patients with ischemia referable to the carotid circulation were treated with intra-arterial urokinase. Angiographic recanalization was assessed at the end of medication infusion. Intracerebral hemorrhage was investigated immediately after and 24 hours after treatment. Stroke severity was determined, followed by long-term outcome. Results-Fifty-four patients were treated. There was improvement of greater than or equal to 4 points on the National Institutes of Health Stroke Scale from presentation to 24 hours after onset in 43% of the treated patients, and this was related to the severity of the initial deficit. Forty-eight percent of patients had a Barthel Index score of 95 to 100 at 90 days, and total mortality was 24%. Cranial CT scans revealed intracerebral hemorrhage in 17% of patients in the first 24 hours, and these patients had more severe deficits at presentation, Eighty-seven percent of patients received intravenous heparin after thrombolysis, and 9% of them developed a hemorrhage into infarction. Angiographic recanalization was the rule in complete occlusions of the horizontal portion of the middle cerebral artery, but distal carotid occlusions responded less well to thrombolysis. Conclusions-The intra-arterial route for thrombolysis allows for greater diagnostic precision and achievement of a higher concentration of the thrombolytic agent in the vicinity of the clot. Disadvantages of this therapy lie in the cost and delay. Severity of stroke and site of angiographic occlusion may be important predictors of successful treatment.
引用
收藏
页码:2094 / 2100
页数:7
相关论文
共 27 条
[1]   TISSUE PLASMINOGEN-ACTIVATOR REDUCES BRAIN INJURY IN A RABBIT MODEL OF THROMBOEMBOLIC STROKE [J].
BEDNAR, MM ;
MCAULIFFE, T ;
RAYMOND, S ;
GROSS, CE .
STROKE, 1990, 21 (12) :1705-1709
[2]  
BOCK BF, 1997, RAPID IDENTIFICATION
[3]   URGENT THERAPY FOR STROKE .1. PILOT-STUDY OF TISSUE PLASMINOGEN-ACTIVATOR ADMINISTERED WITHIN 90 MINUTES [J].
BROTT, TG ;
HALEY, EC ;
LEVY, DE ;
BARSAN, W ;
BRODERICK, J ;
SHEPPARD, GL ;
SPILKER, J ;
KONGABLE, GL ;
MASSEY, S ;
REED, R ;
MARLER, JR .
STROKE, 1992, 23 (05) :632-640
[4]   PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke [J].
del Zoppo, GJ ;
Higashida, RT ;
Furlan, AJ ;
Pessin, MS ;
Rowley, HA ;
Gent, M .
STROKE, 1998, 29 (01) :4-11
[5]   RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE [J].
DELZOPPO, GJ ;
POECK, K ;
PESSIN, MS ;
WOLPERT, SM ;
FURLAN, AJ ;
FERBERT, A ;
ALBERTS, MJ ;
ZIVIN, JA ;
WECHSLER, L ;
BUSSE, O ;
GREENLEE, R ;
BRASS, L ;
MOHR, JP ;
FELDMANN, E ;
HACKE, W ;
KASE, CS ;
BILLER, J ;
GRESS, D ;
OTIS, SM .
ANNALS OF NEUROLOGY, 1992, 32 (01) :78-86
[6]   LOCAL INTRA-ARTERIAL FIBRINOLYTIC THERAPY IN ACUTE CAROTID TERRITORY STROKE - A PILOT-STUDY [J].
DELZOPPO, GJ ;
FERBERT, A ;
OTIS, S ;
BRUCKMANN, H ;
HACKE, W ;
ZYROFF, J ;
HARKER, LA ;
ZEUMER, H .
STROKE, 1988, 19 (03) :307-313
[7]   THROMBOLYTIC THERAPY IN STROKE - POSSIBILITIES AND HAZARDS [J].
DELZOPPO, GJ ;
ZEUMER, H ;
HARKER, LA .
STROKE, 1986, 17 (04) :595-607
[8]   CLINICAL AND INSTRUMENTAL EVALUATION OF PATIENTS WITH ISCHEMIC STROKE WITHIN THE 1ST 6 HOURS [J].
FIESCHI, C ;
ARGENTINO, C ;
LENZI, GL ;
SACCHETTI, ML ;
TONI, D ;
BOZZAO, L .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1989, 91 (03) :311-322
[9]   PILOT-STUDY OF UROKINASE THERAPY IN CEREBRAL INFARCTION [J].
FLETCHER, AP ;
ALKJAERSIG, N ;
LEWIS, M ;
TULEVSKI, V ;
DAVIES, A ;
BROOKS, JE ;
HARDIN, WB ;
LANDAU, WM ;
RAICHLE, ME .
STROKE, 1976, 7 (02) :135-142
[10]  
GORUP TS, 1985, NEW ENGL J MED, V312, P932